ASD Specialty Healthcare, LLC

Carrollton, TX Doing business as Amerisourcebergen Part of Cencora, Inc.

UEI
HJ39FBLVE7L5
CAGE
1M5D9
Primary NAICS
424210 Drugs and Druggists' Sundries Merchant Wholesalers
SAM.gov registration
Active through

Company facts

FY2025 rankings

Its parent company, Cencora, Inc., ranks:

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
5025 Plano Pkwy, Carrollton, TX 75010, USA
Employees
251-1K
Estimated annual revenue
$50M-$100M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
51 Wholesale Trade – Nondurable Goods
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $425,886
FY2026 $583,717
FY2025 -$8,096,427
FY2024 $306,156
FY2023 -$261,517

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Veterans Affairs $773,789
2 Department of Justice $235,814

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

ASD Specialty Healthcare, LLC, operating as Amerisourcebergen and a subsidiary of Cencora, Inc., supplies specialty pharmaceutical products and medical supplies to federal healthcare agencies as a prime contractor on a full-and-open basis, with no SBA certifications. The vendor is headquartered in Carrollton, Texas, and competes across 829 federal contract awards (all prime, zero subs) spanning the past five years, with combined potential value of $74.6 million and $75.2 million obligated.

The vendor's federal footprint concentrates in specialty oncology medications, antivirals, and critical-care pharmaceuticals delivered to Department of Veterans Affairs facilities, Department of the Navy, the Bureau of Prisons, and the Food and Drug Administration. Representative work includes a $183.3 thousand firm fixed-price purchase order from Veterans Integrated Service Network 7 (Atlanta VA Health Care System) for Adstiladrin, a $138.6 thousand order from VISN 10 for BTG Voraxaze, and a $88.4 thousand purchase order from Federal Correctional Complex Butner for Welireg specialty oncology medication. The vendor also executed a $11 million vendor-managed inventory and distribution services contract with the Office of the Assistant Secretary for Preparedness and Response (HHS) for government-furnished medical supplies and pharmaceuticals, awarded September 2022 with completion in March 2023. Recent activity skews toward small-dollar, high-frequency emergency pharmaceutical procurements across multiple VA service networks, ranging from $10 thousand to $46 thousand per order for medications including Amikacin, Balversa (erdafitinib), and Belzutifan (Welireg).

Customer concentration is highly fragmented across forty distinct federal agencies. The top five customers by award count represent 26 percent of all awards and account for roughly $4 million in combined potential value, led by Veterans Integrated Service Network 2 (78 awards, $913 thousand), Veterans Integrated Service Network 8 (47 awards, $736 thousand), and the Department of the Navy Bureau of Medicine and Surgery (38 awards, $795 thousand). When ranked by potential value, Veterans Integrated Service Network 9 anchors the top slot with 11 awards worth $1.4 million, followed by VISN 21 ($1.3 million across 28 awards) and VISN 2 ($913 thousand). The divergence between volume and dollar rankings signals that the vendor wins many small emergency orders from VISN 2 but larger single awards from VISN 9 and 21. Primary NAICS categories reflect pharmaceutical wholesale and manufacturing: Drugs and Druggists' Sundries Merchant Wholesalers (191 awards), Pharmaceutical Preparation Manufacturing (166 awards), and Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42 awards). PSC concentration centers on Drugs and Biologicals (677 awards).

Activity over the past five years shows volatility: 18 awards in 2022, dropping to 6 in 2023, rebounding to 7 in 2024, surging to 28 in 2025, and 10 in 2026 year-to-date. One award reaches completion within the next twenty-four months, carrying $75 thousand in potential value, representing minimal recompete pressure. The vendor places work under a single named Blanket Purchase Agreement (HHSI242201100012B) with 6 task orders valued at $24 thousand. As a subsidiary of Cencora, Inc., ASD Specialty Healthcare operates within a corporate structure that also holds a multi-billion-dollar indefinite delivery contract with the Defense Logistics Agency for comprehensive pharmaceutical and medical supply distribution through December 31, 2031, amplifying the parent's federal healthcare footprint beyond ASD Specialty Healthcare's own direct awards.

Quick answers

Is ASD Specialty Healthcare, LLC registered in SAM.gov?

Yes. ASD Specialty Healthcare, LLC's SAM.gov registration is active through January 2, 2027.

What is ASD Specialty Healthcare, LLC's CAGE code?

ASD Specialty Healthcare, LLC's CAGE code is 1M5D9, and its Unique Entity ID (UEI) is HJ39FBLVE7L5.

How does ASD Specialty Healthcare, LLC rank among federal contractors?

ASD Specialty Healthcare, LLC's parent company, Cencora, Inc., ranked #2 in PSC 65, #2 in NAICS 325 and #10 in NAICS 31-33 in FY2025.

What is ASD Specialty Healthcare, LLC's most recent federal award?

ASD Specialty Healthcare, LLC's most recent federal contract award is Papzimeos immunotherapy (36C26027P0048), from Veterans Integrated Service Network 20 (VHA), on October 20, 2026.

On GovTribe

See ASD Specialty Healthcare, LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe